All product information is provided by the supplier. The National Board of Social Services is not responsible for either contents, origin, flaws and deficiencies, or any kind of damage that may occur from the use of the information. The National Board of Social Services has no authority to endorse products and does not assess the quality of the products. Hide this message.
BioWaveHOME
BioWave, using high-frequency neurostimulation through the skin directly to the pain nerves, inhibits the propagation of the action potential and blocks the transmission of pain signals to the brain.
100 pct. drug-free, wearable, FDA-cleared and CE-certified, smarter pain-blocking technology.
Easy use long-lasting effect. (More than GO)
100 pct. drug-free, wearable, FDA-cleared and CE-certified, smarter pain-blocking technology.
Easy use long-lasting effect. (More than GO)
Classification
04 29 00 01 - Assistive products for pain relief
Documents
BrochureThe product series contains 1 product.
Product 1 of 1
BioWaveHOME
HMI-no.
136804
Article-no.
BWH
Registration date
03-05-2023
Last updated
08-05-2023
Test information
No information about tests according to standards 
The supplier has not provided documentation, that this product is testet according to a relevant standard. See examples of relevant standards for this product type
EU product safety regulation
The supplier has provided the following information about CE-marking of the product. Explain CE-marking
CE marked as medical device